Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome

od Glaspy, John A., Wolf, Myles, Strauss, William E.
Izdano u Adv Ther (2021)

Differential effects of prostaglandin derived from ω-6 and ω-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion

od Bagga, Dilprit, Wang, Ling, Farias-Eisner, Robin, Glaspy, John A., Reddy, Srinivasa T.
Izdano 2003

Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review

od Glaspy, John A, Lim-Watson, Michelle Z, Libre, Michael A, Karkare, Swagata S, Hadker, Nandini, Bajic-Lucas, Aleksandra, Strauss, William E, Dahl, Naomi V
Izdano u Ther Clin Risk Manag (2020)

Pharmacodynamic Characterization of the Efficacy Signals Due to Selective BRAF Inhibition with PLX4032 in Malignant Melanoma

od Tap, William D, Gong, Ke-Wei, Dering, Judy, Tseng, Yiou, Ginther, Charles, Pauletti, Giovanni, Glaspy, John A, Essner, Richard, Bollag, Gideon, Hirth, Peter, Zhang, Chao, Slamon, Dennis J
Izdano 2010

Reversing Melanoma Cross-Resistance to BRAF and MEK Inhibitors by Co-Targeting the AKT/mTOR Pathway

od Atefi, Mohammad, von Euw, Erika, Attar, Narsis, Ng, Charles, Chu, Connie, Guo, Deliang, Nazarian, Ramin, Chmielowski, Bartosz, Glaspy, John A., Comin-Anduix, Begonya, Mischel, Paul S., Lo, Roger S., Ribas, Antoni
Izdano 2011

Long term Survival with CTLA-4 blockade Using Tremelimumab

od Eroglu, Zeynep, Kim, Dae Won, Wang, Xiaoyan, Camacho, Luis H., Chmielowski, Bartosz, Seja, Elizabeth, Villanueva, Arturo, Ruchalski, Kathleen, Glaspy, John A., Kim, Kevin B., Hwu, Wen-Jen, Ribas, Antoni
Izdano u Eur J Cancer (2015)

Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations

od Niehr, Franziska, von Euw, Erika, Attar, Narsis, Guo, Deliang, Matsunaga, Doug, Sazegar, Hooman, Ng, Charles, Glaspy, John A, Recio, Juan A, Lo, Roger S, Mischel, Paul S, Comin-Anduix, Begonya, Ribas, Antoni
Izdano 2011

Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based...

od Raftopoulos, Haralambos, Laadem, Abderrahmane, Hesketh, Paul J., Goldschmidt, Jerome, Gabrail, Nashat, Osborne, Cynthia, Ali, Muhammad, Sherman, Matthew L., Wang, Ding, Glaspy, John A., Puccio-Pick, Marie, Zou, Jun, Crawford, Jeffrey
Izdano u Support Care Cancer (2015)

CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans

od Huang, Rong Rong, Jalil, Jason, Economou, James S., Chmielowski, Bartosz, Koya, Richard C., Mok, Stephen, Sazegar, Hooman, Seja, Elizabeth, Villanueva, Arturo, Gomez-Navarro, Jesus, Glaspy, John A., Cochran, Alistair J., Ribas, Antoni
Izdano 2011

Adenovirus MART-1–engineered Autologous Dendritic Cell Vaccine for Metastatic Melanoma

od Butterfield, Lisa H., Comin-Anduix, Begonya, Vujanovic, Lazar, Lee, Yohan, Dissette, Vivian B., Yang, Jin-Quan, Vu, Hong T., Seja, Elizabeth, Oseguera, Denise K., Potter, Douglas M., Glaspy, John A., Economou, James S., Ribas, Antoni
Izdano 2008

A Randomized Controlled Phase III Trial of Recombinant Human Granulocyte Colony-Stimulating Factor (Filgrastim) for Treatment of Severe Chronic Neutropenia

od Dale, David C., Bonilla, Mary Ann, Davis, Mark W., Nakanishi, Arline M., Hammond, William P., Kurtzberg, Joanne, Wang, Winfred, Jakubowski, Ann, Winton, Elliott, Lalezari, Parviz, Robinson, William, Glaspy, John A., Emerson, Steve, Gabrilove, Janice, Vincent, Martha, Boxer, Laurence A.
Izdano 1993

Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma

od Comin-Anduix, Begoña, Lee, Yohan, Jalil, Jason, Algazi, Alain, de la Rocha, Pilar, Camacho, Luis H, Bozon, Viviana A, Bulanhagui, Cecile A, Seja, Elisabeth, Villanueva, Arturo, Straatsma, Bradley R, Gualberto, Antonio, Economou, James S, Glaspy, John A, Gomez-Navarro, Jesus, Ribas, Antoni
Izdano 2008

Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion

od Ribas, Antoni, Chesney, Jason A, Gordon, Michael S, Abernethy, Amy P, Logan, Theodore F, Lawson, David H, Chmielowksi, Bartosz, Glaspy, John A, Lewis, Karl, Huang, Bo, Wang, Erjian, Hsyu, Poe-Hirr, Gomez-Navarro, Jesus, Gerhardt, Diana, Marshall, Margaret A, Gonzalez, Rene
Izdano 2012

PD-1 blockade expands intratumoral T memory cells

od Ribas, Antoni, Shin, Daniel Sanghoon, Zaretsky, Jesse, Frederiksen, Juliet, Cornish, Andrew, Avramis, Earl, Seja, Elizabeth, Kivork, Christine, Siebert, Janet, Kaplan-Lefko, Paula, Wang, Xiaoyan, Chmielowski, Bartosz, Glaspy, John A., Tumeh, Paul C., Chodon, Thinle, Pe’er, Dana, Comin-Anduix, Begoña
Izdano u Cancer Immunol Res (2016)

Effect of Altering Dietary ω-6/ω-3 Fatty Acid Ratios on Prostate Cancer Membrane Composition, Cyclooxygenase-2, and Prostaglandin E(2)

od Kobayashi, Naoko, Barnard, R. James, Henning, Susanne M., Elashoff, David, Reddy, Srinivasa T., Cohen, Pinchas, Leung, Pak, Hong-Gonzalez, Jenny, Freedland, Stephen J., Said, Jonathan, Gui, Dorina, Seeram, Navindra P., Popoviciu, Laura M., Bagga, Dilprit, Heber, David, Glaspy, John A., Aronson, William J.
Izdano 2006

Focal Irradiation And Systemic Transforming Growth Factor β Blockade in Metastatic Breast Cancer

od Formenti, Silvia C., Lee, Percy, Adams, Sylvia, Goldberg, Judith D., Li, Xiaochun, Xie, Mike W., Ratikan, Josephine A., Felix, Carol, Hwang, Lin, Faull, Kym F., Sayre, James W., Hurvitz, Sara, Glaspy, John A., Comin-Anduix, Begoña, Demaria, Sandra, Schaue, Dörthe, McBride, William H.
Izdano u Clin Cancer Res (2018)

Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma

od Ribas, Antoni, Camacho, Luis H, Lee, Sun Min, Hersh, Evan M, Brown, Charles K, Richards, Jon M, Rodriguez, Maria Jovie, Prieto, Victor G, Glaspy, John A, Oseguera, Denise K, Hernandez, Jackie, Villanueva, Arturo, Chmielowski, Bartosz, Mitsky, Peggie, Bercovici, Nadège, Wasserman, Ernesto, Landais, Didier, Ross, Merrick I
Izdano 2010

Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy

od Shi, Hubing, Hugo, Willy, Kong, Xiangju, Hong, Aayoung, Koya, Richard C., Moriceau, Gatien, Chodon, Thinle, Guo, Rongqing, Johnson, Douglas B., Dahlman, Kimberly B., Kelley, Mark C., Kefford, Richard F., Chmielowski, Bartosz, Glaspy, John A., Sosman, Jeffrey A., van Baren, Nicolas, Long, Georgina V., Ribas, Antoni, Lo, Roger S.
Izdano 2013

Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma

od Ribas, Antoni, Comin-Anduix, Begoña, Chmielowski, Bartosz, Jalil, Jason, de la Rocha, Pilar, McCannel, Tara A., Ochoa, Maria Teresa, Seja, Elizabeth, Villanueva, Arturo, Oseguera, Denise K., Straatsma, Bradley R., Cochran, Alistair J., Glaspy, John A., Hui, Liu, Marincola, Francesco M., Wang, Ena, Economou, James S., Gomez-Navarro, Jesus
Izdano 2009

BRAF L597 mutations in melanoma are associated with sensitivity to MEK inhibitors

od Dahlman, Kimberly Brown, Xia, Junfeng, Hutchinson, Katherine, Ng, Charles, Hucks, Donald, Jia, Peilin, Atefi, Mohammad, Su, Zengliu, Branch, Suzanne, Lyle, Pamela L., Hicks, Donna J., Bozon, Viviana, Glaspy, John A., Rosen, Neal, Solit, David B., Netterville, James L., Vnencak-Jones, Cindy L., Sosman, Jeffrey A., Ribas, Antoni, Zhao, Zhongming, Pao, William
Izdano 2012